XSWX:IDIA (Switzerland)  
Idorsia Ltd logo

Idorsia Ltd

CHF 12.67 (-2.09%) Sep 23
P/E:
At Loss
P/B:
0
Market Cap:
CHF 2.24B ($ 2.26B)
Enterprise V:
CHF 2.71B ($ 2.73B)
Volume:
456.00K
Avg Vol (2M):
440.37K
Also Trade In:
Volume:
456.00K
Market Cap CHF:
2.24B
Market Cap $:
2.26B
PE Ratio:
At Loss
Avg Vol (2-Month):
440.37K
Enterprise Value CHF:
2.71B
Enterprise Value $:
2.73B
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing drugs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.
Name Current Vs Industry Vs History
Cash-To-Debt 0.62
Equity-to-Asset -0.32
Debt-to-Equity -3.58
Debt-to-EBITDA -1.59
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.9
Distress
Grey
Safe
Beneish M-Score -2.48
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 15.39
9-Day RSI 24.38
14-Day RSI 31.61
6-1 Month Momentum % -12.68
12-1 Month Momentum % -31.63

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.1
Quick Ratio 5
Cash Ratio 4.67
Days Sales Outstanding 111.91

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -1749.91
Net Margin % -1851.03
ROE % -1718.29
ROA % -60.8
ROIC % -178.18
ROC (Joel Greenblatt) % -356.63
ROCE % -65.38

Financials

XSWX:IDIA's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 43.779
EPS (TTM) (CHF) -4.67
Beta 0.59
Volatility % 54
14-Day RSI 31.61
14-Day ATR (CHF) 0.530775
20-Day SMA (CHF) 14.0455
12-1 Month Momentum % -31.63
52-Week Range (CHF) 10.83 - 22.94
Shares Outstanding (Mil) 177.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Idorsia Ltd Filings

Document Form Filing Date
No Filing Data

Idorsia Ltd Analysis

Share your research